These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 29507955

  • 21. Predicting IVIG resistance in UK Kawasaki disease.
    Davies S, Sutton N, Blackstock S, Gormley S, Hoggart CJ, Levin M, Herberg JA.
    Arch Dis Child; 2015 Apr; 100(4):366-8. PubMed ID: 25670405
    [Abstract] [Full Text] [Related]

  • 22. The Harada score in the US population of children with Kawasaki disease.
    Tewelde H, Yoon J, Van Ittersum W, Worley S, Preminger T, Goldfarb J.
    Hosp Pediatr; 2014 Jul; 4(4):233-8. PubMed ID: 24986993
    [Abstract] [Full Text] [Related]

  • 23. [Kawasaki disease in children--9 years experience].
    Kowalczyk M, Kawalec W, Daszkowska-York J, Turska-Kmieć A, Brzezińska-Rajszys G, Sobielarska D, Ziółkowska L, Kościesza A, Jagiełłowicz D, Mirecka-Rola A.
    Med Wieku Rozwoj; 2005 Jul; 9(2):179-93. PubMed ID: 16085959
    [Abstract] [Full Text] [Related]

  • 24. Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan.
    Takekoshi N, Kitano N, Takeuchi T, Suenaga T, Kakimoto N, Suzuki T, Kada TT, Shibuta S, Tachibana S, Murayama Y, Yamaga H, Suzuki H.
    JAMA Netw Open; 2022 Jun 01; 5(6):e2216642. PubMed ID: 35696166
    [Abstract] [Full Text] [Related]

  • 25. Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China.
    Tang Y, Yan W, Sun L, Xu Q, Ding Y, Lv H.
    Clin Rheumatol; 2018 Jul 01; 37(7):1945-1951. PubMed ID: 29330741
    [Abstract] [Full Text] [Related]

  • 26. Clinical Presentation and Outcomes of Kawasaki Disease in Children from Latin America: A Multicenter Observational Study from the REKAMLATINA Network.
    Narayan HK, Lizcano A, Lam-Hine T, Ulloa-Gutierrez R, Bainto EV, Garrido-García LM, Estripeaut D, Del Aguila O, Gómez V, Faugier-Fuentes E, Miño-León G, Beltrán S, Cofré F, Chacon-Cruz E, Saltigeral-Simental P, Martínez-Medina L, Dueñas L, Luciani K, Rodríguez-Quiroz FJ, Camacho Moreno G, Viviani T, Alvarez-Olmos MI, Marques HHS, López-Medina E, Pirez MC, Tremoulet AH, Kawasaki Disease REKAMLATINA Network Study Group.
    J Pediatr; 2023 Dec 01; 263():113346. PubMed ID: 36775190
    [Abstract] [Full Text] [Related]

  • 27. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.
    Masuda H, Ae R, Koshimizu TA, Matsumura M, Kosami K, Hayashida K, Makino N, Matsubara Y, Sasahara T, Nakamura Y.
    Pediatr Cardiol; 2021 Apr 01; 42(4):969-977. PubMed ID: 33682062
    [Abstract] [Full Text] [Related]

  • 28. Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey.
    Sudo D, Monobe Y, Yashiro M, Sadakane A, Uehara R, Nakamura Y.
    Pediatr Int; 2010 Oct 01; 52(5):790-4. PubMed ID: 20487371
    [Abstract] [Full Text] [Related]

  • 29. A practical nomogram for predicting coronary thrombosis for Kawasaki disease patients with medium or large coronary artery aneurysm.
    Peng Y, Cheng Z, Yi Q.
    Clin Exp Med; 2023 Aug 01; 23(4):1317-1324. PubMed ID: 36151486
    [Abstract] [Full Text] [Related]

  • 30. Blood routine risk factors for coronary artery aneurysm in infants younger than 8 months with Kawasaki disease.
    Haiyan G, Jianming L, Suqian T, Dong Q, Shuang L, Jin Z.
    BMC Pediatr; 2022 Jan 07; 22(1):29. PubMed ID: 34996405
    [Abstract] [Full Text] [Related]

  • 31. Cardiac Events and the Maximum Diameter of Coronary Artery Aneurysms in Kawasaki Disease.
    Tsuda E, Tsujii N, Hayama Y.
    J Pediatr; 2017 Sep 07; 188():70-74.e1. PubMed ID: 28662948
    [Abstract] [Full Text] [Related]

  • 32. Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease.
    Yamashita M, Ae R, Yashiro M, Aoyama Y, Sano T, Makino N, Nakamura Y.
    Pediatr Cardiol; 2017 Feb 07; 38(2):375-380. PubMed ID: 27878631
    [Abstract] [Full Text] [Related]

  • 33. Effect of different doses of aspirin on the prognosis of Kawasaki disease.
    Wang J, Chen H, Shi H, Zhang X, Shao Y, Hang B, Xu Z, Rong X, Chu M, Qiu H.
    Pediatr Rheumatol Online J; 2020 Jun 11; 18(1):48. PubMed ID: 32527316
    [Abstract] [Full Text] [Related]

  • 34. Regression and Complications of z-score-Based Giant Aneurysms in a Dutch Cohort of Kawasaki Disease Patients.
    Dietz SM, Kuipers IM, Koole JCD, Breur JMPJ, Fejzic Z, Frerich S, Dalinghaus M, Roest AAW, Hutten BA, Kuijpers TW.
    Pediatr Cardiol; 2017 Apr 11; 38(4):833-839. PubMed ID: 28236162
    [Abstract] [Full Text] [Related]

  • 35. The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease.
    Samadli S, Liu FF, Mammadov G, Wang JJ, Liu HH, Wu YF, Luo HH, Wu Y, Chen WX, Zhang DD, Wei W, Hu P.
    Pediatr Rheumatol Online J; 2019 Jul 31; 17(1):53. PubMed ID: 31366406
    [Abstract] [Full Text] [Related]

  • 36. Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment.
    Downie ML, Manlhiot C, Collins TH, Chahal N, Yeung RSM, McCrindle BW.
    Int J Cardiol; 2017 Jun 01; 236():157-161. PubMed ID: 28089146
    [Abstract] [Full Text] [Related]

  • 37. Do we have a less severe form of Kawasaki disease or is it the gammaglobulin effect?
    Abushaban L, Salama A, Uthaman B, Kumar A, Selvan J.
    Int J Cardiol; 1999 Apr 30; 69(1):71-6. PubMed ID: 10362375
    [Abstract] [Full Text] [Related]

  • 38. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
    Berdej-Szczot E, Małecka-Tendera E, Gawlik T, Firek-Pędras M, Szydłowski L, Gawlik A.
    Kardiol Pol; 2017 Apr 30; 75(3):261-266. PubMed ID: 27995598
    [Abstract] [Full Text] [Related]

  • 39. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May 30; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 40. Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).
    Tremoulet AH, Jain S, Kim S, Newburger J, Arditi M, Franco A, Best B, Burns JC.
    Contemp Clin Trials; 2016 May 30; 48():70-5. PubMed ID: 27080929
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.